This course is promoted by Champalimaud Foundation's Fior Lab.
The scientific programme will cover
- Protocols for preparation of human cancer cells for injection;
- Generation of zebrafish xenografts (microinjection in the perivitelline space);
- Metastatic assay;
- Protocols for immunofluorescence;
- Mounting xenografts for confocal imaging;
- Confocal session.
Venue
Champalimaud Center for the Unknown, Lisbon
Dates
30 June - 4 July, 2025 - 9:00
Application
Deadline: 9 May
25 March 2025
In bowel cancer, enlarged lymph nodes can be a good prognostic feature
At the Champalimaud Colorectal Cancer Conference, last February, Gina Brown, from the Imperial College London, questioned the validity of the current staging strategy for colon cancer. Indeed, research shows that lymph nodes are not the main culprit in colon cancer spread, and can actually be a sign that the patient’s immune system is fighting back.
19 March 2025
Can the microbiome provide information about the risk of developing colorectal cancer and its progression?
Coordinated by Professor Ana Santos Almeida, principal investigator of a translational laboratory at the GIMM Foundation - Gulbenkian Institute for Molecular Medicine (GIMM-CARE), this study will take place at the Champalimaud Foundation, in collaboration with Dr. José Azevedo, surgeon of the Colorectal Cancer Group of the Digestive Unit of the Champalimaud Clinical Center, and at the Hospital de Santa Maria, with the participation of oncologists Professor Luís Costa and Dr. André Mansinho.
